NASDAQ: INOInovio Pharmaceuticals Revenue
Inovio Pharmaceuticals revenue was $182.34k for the trailing 12 months ending Jun 30, 2025, with N/A growth year over year. Quarterly revenue for the quarter (Q2 2025) ending on Jun 30, 2025 was $0.0, down 100% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, INO annual revenue was $217.8k, with -73.8% growth year-over-year.
INO past revenue growth
How has INO's revenue growth performed historically?
Company
-69.19%
Industry
107.1%
Market
20.06%
INO's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
INO's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
INO's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance
INO revenue history
Current Revenue
$182.3k
Current Earnings
-$87.8M
Current Profit Margin
-48,131.4%
Be the first to know when INO announces revenue.
INO Revenue History By Year
| INO Yearly Revenue | INO Revenue | INO Change | INO Revenue Growth |
|---|---|---|---|
| 2024-12-31 | $217.76k | -$614.25k | -73.83% |
| 2023-12-31 | $832.01k | -$9.43M | -91.89% |
| 2022-12-31 | $10.26M | $8.49M | +478.23% |
| 2021-12-31 | $1.77M | -$5.64M | -76.05% |
| 2020-12-31 | $7.41M | $3.30M | +80.24% |
| 2019-12-31 | $4.11M | -$26.37M | -86.51% |
| 2018-12-31 | $30.48M | -$11.74M | -27.80% |
| 2017-12-31 | $42.22M | $6.85M | +19.37% |
| 2016-12-31 | $35.37M | -$5.20M | -12.83% |
| 2015-12-31 | $40.57M | $30.12M | +288.00% |
| 2014-12-31 | $10.46M | -$3.01M | -22.35% |
| 2013-12-31 | $13.47M | $9.35M | +226.98% |
| 2012-12-31 | $4.12M | -$5.68M | -57.95% |
| 2011-12-31 | $9.80M | $3.65M | +59.41% |
| 2010-12-31 | $6.14M | -$2.98M | -32.62% |
| 2009-12-31 | $9.12M | $7.02M | +334.78% |
| 2008-12-31 | $2.10M | -$2.71M | -56.37% |
| 2007-12-31 | $4.81M | $1.34M | +38.62% |
| 2006-12-31 | $3.47M | -$2.00M | -36.56% |
| 2005-12-31 | $5.47M | $4.30M | +368.45% |
| 2004-12-31 | $1.17M | $1.09M | +1,349.29% |
| 2003-12-31 | $80.53k | -$108.99k | -57.51% |
| 2002-12-31 | $189.52k | -$4.10M | -95.58% |
| 2001-03-31 | $4.29M | -$786.15k | -15.48% |
| 2000-03-31 | $5.08M | -$3.24M | -38.98% |
| 1999-03-31 | $8.32M | $4.66M | +127.43% |
| 1998-03-31 | $3.66M | $499.41k | +15.81% |
| 1997-02-28 | $3.16M | N/A | N/A |
Inovio Pharmaceuticals Revenue FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.